Has Jeffrey Sharon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,345 in general payments to Jeffrey Sharon, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Sharon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Sharon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Sharon, MD

Otolaryngology · St. Louis, MONPI 1447489968

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $13,515 of the $18,345 with a category attached, or 73.7%. 10 manufacturers reported payments, led by Oticon Medical, LLC at 58.7% of the total. Reporting peaked in 2019 at $11,053 and has fallen 88.2% since, to $1,307 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,345in general payments, 2019–2025

Across 77 payments — averaging $238.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Oticon Medical, LLC$11K
Stryker$5K
Advanced Bionics, LLC$1K
Cochlear Americas$594
Iotamotion, Inc.$212
Med-el Corporation$207
plus $468 from 4 others

$87,977in research payments, 2019–2025

Across 4 payments — averaging $21,994 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Advanced Bionics, LLC$68K
Lilly USA, LLC$20K

What the payments were for

Travel & lodging$13,51574%
Food & beverage$4,83126%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Oticon Medical, LLC	3	$10,763
Stryker	47	$5,074
Advanced Bionics, LLC	11	$1,028
Cochlear Americas	5	$594
Iotamotion, Inc.	2	$212
Med-el Corporation	2	$207
Integra Lifesciences Corporation	2	$197
Lilly USA, LLC	3	$185
AbbVie	1	$59
Inspire Medical Systems, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PONTO BONE ANCHORED HEARING SYSTEM$10,763
N/A$2,737
CORE$1,279
Baha$420
HIRES ULTRA CI HIFOCUS MS ELECTRODE$357
Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$284
OSIA OSI300 IMPLANT$284
HiResolution Bionic Ear System$214
Nucleus$136
iotaSOFT$135
Acclarent Aera$134
Inspira Air$134
RELIEVA SPINPLUS NAV$134
TruDi Probe$134
Mi1250 SYNCHRONY 2 FLEXsoft$106
MED-EL Maestro Cochlear Implant System$100

How this compares

$18,345 in reported general payments places this provider in the 95th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri →

Medicare billing

Part B allowed, 2024

$61,142

Medicare patients

161

Services billed

284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Emgality PenGalcanezumab-Gnlm	16	$28,791
Ofloxacin	15	$526
Nortriptyline Hcl	13	$492
Venlafaxine Hcl ErVenlafaxine Hcl	17	$46

Paid to pharmacies, not to this prescriber.

Other otolaryngology in St. Louis

Joseph BrunworthSt. Louis$7K
Talon ManingasJoplin$314K
Ryan JacksonSaint Louis$284K
Ravindra UppaluriSaint Louis$168K
James GouldFestus$143K
John SchneiderSaint Louis$74K
Amit WaliaSaint Louis$21K
Bharat PanugantiSaint Louis$19K
Kelvin WallsLees Summit$14K
Cristine Klatt-CromwellSaint Louis$13K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →